SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52153 679 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
52078Good strategy, Art. Unfortunately, I am holding my FGEN in a tax-deferred accounFrank Sauer-7/11/2023
52077Frank -- FGEN lost 80% of its market value on news that its pamrevlumab drug didArt Bechhoefer-7/10/2023
52076Thank you for sharing your thoughts, Art. What I usually don't want to do inFrank Sauer-7/7/2023
52075KZIA gets FDA Fast Track Designation for paxalisib: SYDNEY, July 6, 2023 /PRNewsAloner-7/6/2023
52074Frank -- I sold some of my FGEN holdings near $17, before the news that brought Art Bechhoefer17/5/2023
52073Ouch to the recent news release. Are you still a shareholder, Art? I had kept myFrank Sauer-7/3/2023
52072Another trial failure sends stock price to lowest ever. fiercebiotech.comA.J. Mullen-6/28/2023
52071And now what I expect to be the final post in this minor pharmadrama, SurVeil isLance Bredvold-6/20/2023
52070Now we see that both the Needham recommendation (which happened Tues) and an annLance Bredvold-6/14/2023
52069Wow, that Needham must have a lot of clout. I pay no attention to any analysts Lance Bredvold-6/13/2023
52068Good news/ bad news (or the reverse for some) from ft.com. The good news is tA.J. Mullen-6/13/2023
52067Needham upgraded SRDX today. It's a fine company that I owned several years DewDiligence_on_SI-6/13/2023
52066SRDX; Surmodics, Surface modification. I'm not really certain you would conLance Bredvold36/13/2023
52065The reason IMGN is up only 5% today is that most of the Elahere data presented aDewDiligence_on_SI-6/5/2023
52064Great news from IMGN ASCO presentation this morning: ELAHERE® DemonstrateFJV-6/4/2023
52063Another reason to get a tumor genotyped. Taking a daily dose of osimertinib halA.J. Mullen26/4/2023
52062Illumina's been shot in the foot by a partner of its subsidiary, Grail, finaA.J. Mullen-6/2/2023
52061Re: another Sell trade on the CRSP core position............... [graphic] TotaOldAIMGuy-5/23/2023
52060Twist Bioscience up 15% on Announcement of a Portfolio of RNA Sequencing Tools, A.J. Mullen15/22/2023
52059Up another 30% today: Corvus Pharmaceuticals to Present New CPI-818 Data at theAloner-5/17/2023
52058CRVS is up almost 80% in last 5 days of trading: seekingalpha.comAloner15/15/2023
52057Re: CRSP......... I've only owned CRSP about a year now. It's been a roOldAIMGuy-5/11/2023
52056Positive Individualized Pancreatic Cancer Vaccine news from BioNTech: nature.coAloner35/11/2023
52055It's up 33% now. I listened to the call. They are partnered with San DiegoA.J. Mullen-5/9/2023
52054Voyager Therapeutics up 20% today, the day they published earnings, finance.yahoA.J. Mullen-5/9/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News